omega-n-methylarginine has been researched along with Hypertension, Essential in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellien, J; Blot, E; Donnadieu, N; Dreano, Y; Gutierrez, L; Iacob, M; Joannides, R; Lucas, D; Mercier, A; Remy-Jouet, I; Thuillez, C | 1 |
1 other study(ies) available for omega-n-methylarginine and Hypertension, Essential
Article | Year |
---|---|
Impaired role of epoxyeicosatrienoic acids in the regulation of basal conduit artery diameter during essential hypertension.
Topics: Adult; Blood Pressure; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Eicosanoids; Endothelium, Vascular; Essential Hypertension; Female; Fluconazole; Humans; Hypertension; Male; Middle Aged; omega-N-Methylarginine; Radial Artery; Regional Blood Flow; Vasoconstriction; Vasodilation | 2012 |